Literature DB >> 22089255

Thalidomide treatment in cirrhotic patients with severe anemia secondary to vascular malformations.

Antonio Garrido Serrano, Rafael León, Manuel Sayago, Jose Luis Márquez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22089255     DOI： 10.1007/s10620-011-1971-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  9 in total

1.  Somatostatin analogues for bleeding gastrointestinal angiodysplasias: when should thalidomide be prescribed?

Authors:  Javier Molina-Infante; Belen Perez-Gallardo
Journal:  Dig Dis Sci       Date:  2011-01       Impact factor: 3.199

2.  Induction of HGF and VEGF in hepatic regeneration after hepatotoxin-induced cirrhosis in mice.

Authors:  Nilgün Tekkesin; Yavuz Taga; Aydin Sav; Idil Almaata; Duygu Ibrisim
Journal:  Hepatogastroenterology       Date:  2011 May-Jun

3.  Thalidomide in refractory haemorrhagic radiation induced proctitis.

Authors:  M E Craanen; B van Triest; R H M Verheijen; C J J Mulder
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

4.  Thalidomide-induced severe hepatotoxicity.

Authors:  A James Hanje; Jennifer L Shamp; Fred B Thomas; Greg M Meis
Journal:  Pharmacotherapy       Date:  2006-07       Impact factor: 4.705

5.  Macroscopic appearance of intestinal angiodysplasias under antiangiogenic treatment with thalidomide.

Authors:  J Bauditz; H Lochs; W Voderholzer
Journal:  Endoscopy       Date:  2006-10       Impact factor: 10.093

6.  Refractory bleeding from portal hypertensive gastropathy: a further novel role for thalidomide therapy?

Authors:  Mohammed A Karajeh; David P Hurlstone; Tim J Stephenson; Dominic Ray-Chaudhuri; Dermot C Gleeson
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-05       Impact factor: 2.566

7.  Efficacy and safety of thalidomide in patients with hepatocellular carcinoma.

Authors:  Hsueh-Erh Chiou; Tsang-En Wang; Ying-Yue Wang; Hui-Wen Liu
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

8.  Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation.

Authors:  Zhi-Zheng Ge; Hui-Min Chen; Yun-Jie Gao; Wen-Zhong Liu; Chun-Hong Xu; Hong-Hong Tan; Hai-Ying Chen; Wei Wei; Jing-Yuan Fang; Shu-Dong Xiao
Journal:  Gastroenterology       Date:  2011-07-22       Impact factor: 22.682

9.  Thalidomide for the treatment of chronic gastrointestinal bleeding from angiodysplasias: a case series.

Authors:  Patarapong Kamalaporn; Ramasamy Saravanan; Maria Cirocco; Gary May; Paul Kortan; Gabor Kandel; Norman Marcon
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-12       Impact factor: 2.566
  9 in total
  9 in total

1.  Antiinflammation and Antioxidant Effects of Thalidomide on Pulmonary Fibrosis in Mice and Human Lung Fibroblasts.

Authors:  Xiaoying Dong; Xin Li; Minghui Li; Ming Chen; Qian Fan; Wei Wei
Journal:  Inflammation       Date:  2017-12       Impact factor: 4.092

2.  Vincamine prevents lipopolysaccharide induced inflammation and oxidative stress via thioredoxin reductase activation in human corneal epithelial cells.

Authors:  Li Wu; Meihong Ye; Jie Zhang
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

3.  Inhibitory effects of thalidomide on bleomycin-induced pulmonary fibrosis in rats via regulation of thioredoxin reductase and inflammations.

Authors:  Xiaoying Dong; Xin Li; Minghui Li; Ming Chen; Qian Fan; Wei Wei
Journal:  Am J Transl Res       Date:  2017-10-15       Impact factor: 4.060

Review 4.  Emerging role of thalidomide in the treatment of gastrointestinal bleeding.

Authors:  Michael McFarlane; Lauren O'Flynn; Rachel Ventre; Benjamin R Disney
Journal:  Frontline Gastroenterol       Date:  2017-11-02

Review 5.  Effective treatment of gastrointestinal bleeding with thalidomide--Chances and limitations.

Authors:  Juergen Bauditz
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

Review 6.  Iron Deficiency and the Small bowel​.

Authors:  David Westrich; Christine Hachem; Christine Boumitri
Journal:  Curr Gastroenterol Rep       Date:  2021-07-08

7.  The Use of Thalidomide in Severe Refractory Anaemia Due to Gastric Antral Vascular Ectasia (GAVE) in Cirrhosis?

Authors:  Marcelo Aveiro; Tatiana Rodrigues; Tiago Rabadão; Filipa Ferreira; Mariana Teixeira; Ana Oliveira; Inês Vasconcelos
Journal:  Eur J Case Rep Intern Med       Date:  2020-11-18

8.  Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide.

Authors:  Haiying Chen; Sengwang Fu; Nan Feng; Huimin Chen; Yunjie Gao; Yunjia Zhao; Hanbing Xue; Yao Zhang; Xiaobo Li; Jun Dai; Jingyuan Fang; Zhizheng Ge
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Thalidomide for the treatment of angiodysplasia-related recurrent gastrointestinal hemorrhage: Is low dose a safe and viable option?

Authors:  Harish Patel; Shehriyar Mehershahi; Danial Haris Shaikh; Jasbir Makker; Sureshkumar Nayudu; Prospere Remy; Sridhar Chilimuri
Journal:  Clin Case Rep       Date:  2019-10-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.